ProMarkerD: Diabetic Kidney Disease Risk
Test Introduction
Test Description
PromarkerD is based on the measurement of three novel plasma protein biomarkers (ApoA4, CD5L and IGFBP3) using a standard immunoassay (ELISA) platform. The biomarker concentrations are combined with 3 clinical factors (age, HDL-cholesterol and eGFR) measured at the time of the test. The combined raw data is submitted to the PromarkerD Hub, and a test report with the patient risk score (0-100) and risk category (low-, moderate-, or high-risk) is generated. This risk prediction is concerned with the trajectory of the patientsʼ eGFR over 4 years. A rapidly declining eGFR is one of the strongest indicators of significant renal problems and the progression of diabetic kidney disease.
Blood sample

A sample is drawn at clinic or pathology laboratory and sent to PacificDx for analysis
Biomarker analysis

Analysis software

Cloud-based algorithm calculates patient kidney disease risk score
Patient is classified as LOW RISK, MODERATE RISK, or HIGH RISK
Intervention plan

A personalised intervention/ management plan is created
Test Ordering
Sample Collection and Shipping Instructions
ProMarkerD is available for purchase directly through the ProMarkerD website. Acceptable sample types are Blood collected in K2-EDTA tubes. Collect a total of 20 mL of whole blood into the 2 K2-EDTA tubes, and ship at 15-25C within 24 hrs of collection.
